BCAS3 antibody (C-Term)
Quick Overview for BCAS3 antibody (C-Term) (ABIN7453844)
Target
See all BCAS3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- Rabbit anti-BCAS3 Antibody, Affinity Purified
-
Predicted Reactivity
- Mouse
-
Purification
- Affinity Purified
-
Immunogen
- between AA 870 and C-term
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IHC: 1:100 - 1:500. Epitope retrieval with citrate buffer pH 6.0 or Tris-EDTA pH 9.0 is recommended for FFPE tissue sections.
IP: 2 - 5 μg/mg lysate
WB: 1:2,000 - 1:10,000
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- Tris-buffered Saline containing 0.1 % BSA and 0.09 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Expiry Date
- 12 months
-
-
- BCAS3 (Breast Carcinoma Amplified Sequence 3 (BCAS3))
-
Alternative Name
- BCAS3
-
Background
- Background: Breast cancer amplified sequence 3 (BCAS3) was identified as a gene overexpressed and amplified in breast cancer cell lines. BCAS3 expression has been shown to be regulated by estrogen receptor alpha (ER alpha) and its coregulator PELP1 (proline-, glutamic acid-, and leucine-rich protein 1). BCAS3 has also been demonstrated to act as a coactivator of ER alpha activity in breast cancer cells and associate with the histone acetyltransferase complex protein P/CAF (p300/CBP-associated factor).
-
Gene ID
- 54828
-
UniProt
- Q9H6U6
Target
-